Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
summary of resources 4.1 .
summary of resources 4.1 .
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
note for guidance on summary of requirements for active substances in part ii of the dossier
note for guidance on summary of requirements for active substances in part ii of the dossier
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
titel på dokumentet antimicrobials for veterinary use summary of product characteristics for antimicrobial products ectoparasiticide guidance for sheep, cattle and goats fluid therapy
asiakirjan nimi antimicrobials for veterinary use summary of product characteristics for antimicrobial products ectoparasiticide guidance for sheep, cattle and goats fluid therapy
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
titel på dokumentet antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
asiakirjan nimi antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)
prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
summary of questions and options - annex to the interim report on the european monetary system - ( heyveart report no. 39 )
summary of questions and options - annex to the interim report on the european monetary system - ( heyveart report no. 39 )
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
grundlag af den forelagte dokumentation, den faglige drøftelse i udvalget og den foreslåede ordlyd i den ajourførte udgave af guideline on summary of product characteristics fra oktober 2005 og den seneste qrd- model,
2005
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
på grund af den betydning, som adækvat smertebehandling af moderen må tillægges, kan chmp i overensstemmelse med "guideline on summary of product characteristics" tilslutte sig, at den forslåede tekst forbliver i pkt.
tämä tarkoittaa, että valmistetta voidaan antaa imettäville äideille, mutta imetys on keskeytettävä fentanyylilaastareiden käytön ajaksi, ja imetystä saa jatkaa aikaisintaan 72 tuntia laastarin poistamisen jälkeen.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
grundlag af den forelagte dokumentation, den faglige drøftelse i udvalget og den foreslåede ordlyd i den ajourførte udgave af guideline on summary of product characteristics fra oktober 2005 og de seneste qrd- modeller (version 7),
2005
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.